Collaboration | Ophthalmology Innovation Source

Makower: Making Medtech Bigger, Stronger, Faster

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 054″] Josh Makower, MD, literally wrote (or co-wrote) the book on Medtech Innovation. Makower is a general partner in New Enterprise Associates most recent fund, but he’s worked with the firm as a Venture Partner or EIR since 1995. Makower founded ExploraMed I, II, III, and IV Inc., a series of…

Clarus Delivers Good News With $500m Fund

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 048″] OIS Co-Chair Emmett Cunningham explains how Clarus will invest new $500m fund in ophthalmology and beyond. Podcast Guest Emmett T. Cunningham Jr., MD, PhD, MPH Dr. Cunningham joined Clarus Ventures with 20+ years in the biomedical and biopharmaceutical sectors. Prior, Dr. Cunningham was the SVP, Medical Strategy at Eyetech Pharmaceuticals.…

A Discussion Of Allergan’s Legacy And Future In Medtech Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 045″] Hear from Allergan’s Past and Future: Highlights of interviews with Brent Saunders and Gavin Herbert. Podcast Guest Brent Saunders Brent Saunders has served as CEO and President of Allergan, formerly Actavis, since July 1, 2014. Previously, Mr. Saunders served as CEO and President of Forest Laboratories from 2013 to 2014.…

Here is How Big Companies Innovate

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 044″] Leaders of Alcon, AMO, Valeant and Zeiss Discuss the Role of Innovation in their Success. Podcast Transcript Tom Salemi: Hi, welcome back to the OIS Podcast. This is Tom Salemi, your host. Thank you so much for joining us today. If you tuned in last week, you heard from J.…

Borrmann Gives View Into Abbott’s Innovation Cycle

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 041″] Leonard Borrmann, Head of R&D at Abbott Medical Optics, explains how the company encourages “failing forward” and other innovative qualities to creating new vision devices. Podcast Guest Leonard Borrmann Leonard joined Abbott as Divisional Vice President R&D, in February 2009, with the acquisition of Advanced Medical Optics. During his five…

Alternative Financing Approaches

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 036″] As venture investors shift to later stages, start-ups will have to look harder for new sources of innovation. A panel at OIS@ASCRS discusses how new sources of capital can sustain the creation of new companies.

Co-Chair Link Gives Overview Of Upcoming OIS

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 033″] With just two weeks away from OIS@ASCRS, Conference Co-Chair Bill Link, managing director of Versant Ventures, reviews the highlights of the upcoming meeting including a tight focus on glaucoma and plenary talk by J. Michael Pearson of Valeant. Podcast Guests William J. Link, PhD Bill was Founder, Chairman and CEO…

Alcon’s Attias Offers Insights On Innovation

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 032″]

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

Laurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the Ora System’s potential. Also, Attias adds his insights on the fascinating joint venture between Alcon and Google to develop a next generation contact lens. Speaking With: Laurent Attias Laurent Attias…

Jeff George’s Vision for Innovation at Alcon

Jeff George, Global Head of Alcon, took a few minutes between panels and meetings to share his vision for innovation at Alcon and how the company will pursue many opportunities in ophthalmology. Speaking With: Jeff George Jeff was appointed to lead Alcon in May 2014. As the global leader in eye care, Alcon provides innovative…

CEOs Share Lessons from IPOs

A panel of ophthalmology executives at the Ophthalmology Innovation Summit discuss the perks and pitfalls of going public. Moderator: David Guyer, MD Under Dr. Guyer’s leadership, Ophthotech raised more than $350 million in financing from May to September 2013, including a $192 million IPO, a multi-tranched $125 million royalty financing deal with Novo A/S and…

Google Eyes Ophthalmology

Google and Alcon executives shared the stage to answer some questions about thier unique partnership. Alcon executives Laurent Attias, Head, Global Commercial Strategy and Franck Leveiller, PhD, VP, Head of Research & Development Vision Care and Brian P. Otis, PhD, founder of the Smart Contact LensProject at Google X answered questions from OIS Co-Chair Gil…